LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinase
Neuroblastoma is an aggressive pediatric malignancy of the neural crest with suboptimal cure rates and a striking predilection for widespread metastases, underscoring the need to identify novel therapeutic vulnerabilities. We recently identified the RNA binding protein LIN28B as a driver in high-ris...
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-06-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558620301135 |
id |
doaj-ad151ae47c9f49dea91c5b91b570dcb8 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Dongdong Chen Julie Cox Jayabhargav Annam Melanie Weingart Grace Essien Komal S. Rathi Jo Lynne Rokita Priya Khurana Selma M. Cuya Kristopher R. Bosse Adeiye Pilgrim Daisy Li Cara Shields Oskar Laur John M. Maris Robert W. Schnepp |
spellingShingle |
Dongdong Chen Julie Cox Jayabhargav Annam Melanie Weingart Grace Essien Komal S. Rathi Jo Lynne Rokita Priya Khurana Selma M. Cuya Kristopher R. Bosse Adeiye Pilgrim Daisy Li Cara Shields Oskar Laur John M. Maris Robert W. Schnepp LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinase Neoplasia: An International Journal for Oncology Research Neuroblastoma LIN28B Let-7 PDZ binding kinase Metastasis |
author_facet |
Dongdong Chen Julie Cox Jayabhargav Annam Melanie Weingart Grace Essien Komal S. Rathi Jo Lynne Rokita Priya Khurana Selma M. Cuya Kristopher R. Bosse Adeiye Pilgrim Daisy Li Cara Shields Oskar Laur John M. Maris Robert W. Schnepp |
author_sort |
Dongdong Chen |
title |
LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinase |
title_short |
LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinase |
title_full |
LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinase |
title_fullStr |
LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinase |
title_full_unstemmed |
LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinase |
title_sort |
lin28b promotes neuroblastoma metastasis and regulates pdz binding kinase |
publisher |
Elsevier |
series |
Neoplasia: An International Journal for Oncology Research |
issn |
1476-5586 |
publishDate |
2020-06-01 |
description |
Neuroblastoma is an aggressive pediatric malignancy of the neural crest with suboptimal cure rates and a striking predilection for widespread metastases, underscoring the need to identify novel therapeutic vulnerabilities. We recently identified the RNA binding protein LIN28B as a driver in high-risk neuroblastoma and demonstrated it promotes oncogenic cell proliferation by coordinating a RAN-Aurora kinase A network. Here, we demonstrate that LIN28B influences another key hallmark of cancer, metastatic dissemination. Using a murine xenograft model of neuroblastoma dissemination, we show that LIN28B promotes metastasis. We demonstrate that this is in part due to the effects of LIN28B on self-renewal and migration, providing an understanding of how LIN28B shapes the metastatic phenotype. Our studies reveal that the let-7 family, which LIN28B inhibits, decreases self-renewal and migration. Next, we identify PDZ Binding Kinase (PBK) as a novel LIN28B target. PBK is a serine/threonine kinase that promotes the proliferation and self-renewal of neural stem cells and serves as an oncogenic driver in multiple aggressive malignancies. We demonstrate that PBK is both a novel direct target of let-7i and that MYCN regulates PBK expression, thus elucidating two oncogenic drivers that converge on PBK. Functionally, PBK promotes self-renewal and migration, phenocopying LIN28B. Taken together, our findings define a role for LIN28B in neuroblastoma metastasis and define the targetable kinase PBK as a potential novel vulnerability in metastatic neuroblastoma. |
topic |
Neuroblastoma LIN28B Let-7 PDZ binding kinase Metastasis |
url |
http://www.sciencedirect.com/science/article/pii/S1476558620301135 |
work_keys_str_mv |
AT dongdongchen lin28bpromotesneuroblastomametastasisandregulatespdzbindingkinase AT juliecox lin28bpromotesneuroblastomametastasisandregulatespdzbindingkinase AT jayabhargavannam lin28bpromotesneuroblastomametastasisandregulatespdzbindingkinase AT melanieweingart lin28bpromotesneuroblastomametastasisandregulatespdzbindingkinase AT graceessien lin28bpromotesneuroblastomametastasisandregulatespdzbindingkinase AT komalsrathi lin28bpromotesneuroblastomametastasisandregulatespdzbindingkinase AT jolynnerokita lin28bpromotesneuroblastomametastasisandregulatespdzbindingkinase AT priyakhurana lin28bpromotesneuroblastomametastasisandregulatespdzbindingkinase AT selmamcuya lin28bpromotesneuroblastomametastasisandregulatespdzbindingkinase AT kristopherrbosse lin28bpromotesneuroblastomametastasisandregulatespdzbindingkinase AT adeiyepilgrim lin28bpromotesneuroblastomametastasisandregulatespdzbindingkinase AT daisyli lin28bpromotesneuroblastomametastasisandregulatespdzbindingkinase AT carashields lin28bpromotesneuroblastomametastasisandregulatespdzbindingkinase AT oskarlaur lin28bpromotesneuroblastomametastasisandregulatespdzbindingkinase AT johnmmaris lin28bpromotesneuroblastomametastasisandregulatespdzbindingkinase AT robertwschnepp lin28bpromotesneuroblastomametastasisandregulatespdzbindingkinase |
_version_ |
1724814991664611328 |
spelling |
doaj-ad151ae47c9f49dea91c5b91b570dcb82020-11-25T02:33:18ZengElsevierNeoplasia: An International Journal for Oncology Research1476-55862020-06-01226231241LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinaseDongdong Chen0Julie Cox1Jayabhargav Annam2Melanie Weingart3Grace Essien4Komal S. Rathi5Jo Lynne Rokita6Priya Khurana7Selma M. Cuya8Kristopher R. Bosse9Adeiye Pilgrim10Daisy Li11Cara Shields12Oskar Laur13John M. Maris14Robert W. Schnepp15Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Children’s Healthcare of Atlanta, Atlanta, GA 30322, USADivision of Oncology and Center for Childhood Cancer Research, Children’s Hospital of Philadelphia, Philadelphia, PA 19104, USAAflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Children’s Healthcare of Atlanta, Atlanta, GA 30322, USADivision of Oncology and Center for Childhood Cancer Research, Children’s Hospital of Philadelphia, Philadelphia, PA 19104, USAAflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Children’s Healthcare of Atlanta, Atlanta, GA 30322, USACenter for Data-Driven Discovery in Biomedicine, Children’s Hospital of Philadelphia, Philadelphia, PA 19104, USA; Department of Bioinformatics and Health Informatics, Children’s Hospital of Philadelphia, Philadelphia, PA 19104, USACenter for Data-Driven Discovery in Biomedicine, Children’s Hospital of Philadelphia, Philadelphia, PA 19104, USA; Department of Bioinformatics and Health Informatics, Children’s Hospital of Philadelphia, Philadelphia, PA 19104, USADivision of Oncology and Center for Childhood Cancer Research, Children’s Hospital of Philadelphia, Philadelphia, PA 19104, USAAflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Children’s Healthcare of Atlanta, Atlanta, GA 30322, USADivision of Oncology and Center for Childhood Cancer Research, Children’s Hospital of Philadelphia, Philadelphia, PA 19104, USA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USAAflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Children’s Healthcare of Atlanta, Atlanta, GA 30322, USAAflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Children’s Healthcare of Atlanta, Atlanta, GA 30322, USAAflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Children’s Healthcare of Atlanta, Atlanta, GA 30322, USAEmory Cloning Division EIGC, USADivision of Oncology and Center for Childhood Cancer Research, Children’s Hospital of Philadelphia, Philadelphia, PA 19104, USA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USAAflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Children’s Healthcare of Atlanta, Atlanta, GA 30322, USA; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA; Corresponding author at: Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine Health Sciences Research Building, Room E304, 1760 Haygood Drive, Atlanta, GA 30322Neuroblastoma is an aggressive pediatric malignancy of the neural crest with suboptimal cure rates and a striking predilection for widespread metastases, underscoring the need to identify novel therapeutic vulnerabilities. We recently identified the RNA binding protein LIN28B as a driver in high-risk neuroblastoma and demonstrated it promotes oncogenic cell proliferation by coordinating a RAN-Aurora kinase A network. Here, we demonstrate that LIN28B influences another key hallmark of cancer, metastatic dissemination. Using a murine xenograft model of neuroblastoma dissemination, we show that LIN28B promotes metastasis. We demonstrate that this is in part due to the effects of LIN28B on self-renewal and migration, providing an understanding of how LIN28B shapes the metastatic phenotype. Our studies reveal that the let-7 family, which LIN28B inhibits, decreases self-renewal and migration. Next, we identify PDZ Binding Kinase (PBK) as a novel LIN28B target. PBK is a serine/threonine kinase that promotes the proliferation and self-renewal of neural stem cells and serves as an oncogenic driver in multiple aggressive malignancies. We demonstrate that PBK is both a novel direct target of let-7i and that MYCN regulates PBK expression, thus elucidating two oncogenic drivers that converge on PBK. Functionally, PBK promotes self-renewal and migration, phenocopying LIN28B. Taken together, our findings define a role for LIN28B in neuroblastoma metastasis and define the targetable kinase PBK as a potential novel vulnerability in metastatic neuroblastoma.http://www.sciencedirect.com/science/article/pii/S1476558620301135NeuroblastomaLIN28BLet-7PDZ binding kinaseMetastasis |